Genmab — April 2021
-
Jeps..bull´s er ikke for sarte sjæle:-)
-
US notering +1,18% . NBI ender nok i plus.
-
Who knows what tomorrow brings
In a world few hearts survive
All I know is the way I feel
When it's real, I keep it alive
The road is long
There are mountains in our way
But we climb a step every day
Love lift us up where we belong
Where the eagles cry
On a mountain high
Love lift us up where we belong
Far from the world belowUp where the clear winds blow
-
God morgen.
-
Onsdagens aviser med Danske Bank, Genmab og Gyldendal
https://www.proinvestor.com/investornyt/674235/onsdagens-aviser-med-danske-bank-genmab-og-gyldendal -
Roche Q1 Investor presentation. Ocrevus på side 23
-
MS franchise: Ocrevus with 26% total US market share
Market leadership maintained -
Side 51 fase 3 studier hvor Mosunetuzumab og Glofitamab er med
-
Iflg side 52 forventes Mosunetuzumab submitted i år og Glofitamab næste år
-
Godmorgen @GB. Hvorfor sælger Ocrevus så lidt uden for US?
-
Det ved jeg ikke
-
Du ved ellers så meget
Jeg leder på egen hånd -
@LLI De har nok glemt at oversætte indlægssedlen ;-
) -
Thx EL - no time to stop and smell the flowers
-
it looks like that for the first filings, but we
know glofi also has FL expansian cohorts and vice versa, so maybe it is too early to say? presentation shows the trials https://www.roche.com/dam/jcr:3a48ad2b-c695-462c-a42f-ffcae34fa39c/en/irp210421.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind